Pancreatic Cancer Halted by Virus Injection in Three Patients
20th November 2026
Three people with inoperable pancreatic cancer had stable disease after receiving an experimental virus treatment in a University of Minnesota Phase I trial. The university first reported the findings in June 2026. In a fall follow-up, it said one participant had reached 15 months of disease control.
The treatment uses a genetically engineered adenovirus injected into a tumor. It aims to enter malignant cells, replicate within them, and destroy them, potentially making the cancer easier for the immune system to recognize.
“Halted” in this setting refers to the reported control of disease during follow-up. It should not be read as proof that every cancer cell was eliminated, that tumors disappeared or that the treatment has been shown to extend survival compared with standard care.